News About: Pharm. Industry
Pharma industry, “It’s insufficient only with drugs, thus active with business diversification”
The trend of business diversification has been fueled in the pharmaceutical industry. In accordance with the judgement that it is hard to survive only with pharmaceutical products, pharmaceutical companies are activel...
Dongkook enters blood glucose monitoring market along with international companyDongkook Pharmaceutical held a signing ceremony with an international diabetes management company, Ascensia Diabetes Care, at its head office on the 7th, and signed a approval a...
|
Listed pharmas’ surpluses reach KRW 8.9 trillion, Yuhan owns KRW 1.36 trillion
It was observed the amount of surpluses owned by listed pharmaceutical companies reach KRW 8.9 trillion, and Yuhan Corporation owns the largest amount, KRW 1.3614 trillion.
According to the Yakup Shinmoon’s(www.yaku...
Janssen, “Partnership with Hanmi is still strong, and it’s only suspended, not terminated”“Hanmi Pharm and Janssen’s partnership is still strong, and we hope to continue the clinical trial as soon as possible,” Janssen which owns the license of HM12525A, a Hanmi Phar...
|
Hanmi, “Clinical trials of new drug transferred to Janssen has never been suspended”
When it comes to the online article from an economic newspaper on the 7th, ‘Hanmi Pharm suspends clinical trial of the drug candidate transferred to Janssen,’ Hanmi Pharm announced that the clinical trial of the new d...
MSD Korea exceeded KRW 20 billion annual sales for hyperlipidemia complex AtozetMSD Korea(CEO Avi BenShoshan) announced on the 6th that the hyperlipidemia therapy ‘Atozet(generic name: ezetimibe/atorvastatin)’ made annual sales of KRW 20 billion and recorde...
|
Celltrion Group Chairman Jung-Jin Seo lead aggressive movements for Remsima to U.S. marketAn event to celebrate the U.S. launch of the Celltrion’s antibody biosimilar, Remsima(U.S. name: Inflectra) was held on the 5th of December(local time) in Las Vegas, USA.
In or...
|
KSPM appointed Executive Janssen Korea Director Sung-Ja Cho as 12th President
The Korean Society of Pharmaceutical Medicine(KSPM) appointed Sung-Ja Cho, an executive director at Janssen Korea, as the 12th new president at its 2016 regular general meeting held at the Catholic Univ. of Korea Seou...
Huons, Han Wha, Daewon & IntroPharm lost patent trial of ‘Regpara Tab’
At the patent nullification trial for ‘Regpara Tab,’ filed by multiple companies like Huons, the Korean Intellectual Property Tribunal made a favorable ruling for the patentee, ‘Shire-NPS Pharmaceuticals Inc.’
Accord...
Pharmaceutical exports reach KRW 3.33 trillion
The last year’s pharmaceutical exports were KRW 3.33 trillion, accounting for 0.56% of the total Korean exports.
According to the Ministry of Food and Drug Safety, the 2015’s total pharmaceutical exports were KRW 3.3...
